Molecular Biology of the Cell Call for Nominations: MBC Editor-in-Chief

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
QUICK SEARCH:   [advanced]


     

MBC in Press, published online ahead of print July 7, 2004
Mol. Biol. Cell 10.1091/mbc.E03-12-0890

A more recent version of this article appeared on September 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
E03-12-0890v1
15/9/4023    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mullershausen, F.
Right arrow Articles by Friebe, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mullershausen, F.
Right arrow Articles by Friebe, A.

Submitted on December 15, 2003
Revised on June 17, 2004
Accepted on June 28, 2004

In Vivo Reconstitution of the Negative Feedback in NO/cGMP Signaling: Role of Phosphodiesterase Type 5 Phosphorylation

Florian Mullershausen, Michael Russwurm, Doris Koesling, and Andreas Friebe*

Institut für Pharmakologie und Toxikologie, Medizinische Fakultät, Ruhr-Universität Bochum, Bochum, Germany

Monitoring Editor: Guido Guidotti

Most effects of the messenger molecule NO are mediated by cGMP which is formed by NO-sensitive guanylyl cyclase (GC) and degraded by phosphodiesterases (PDE). In platelets, NO elicits a spike-like cGMP response and causes a sustained desensitization. Both characteristics have been attributed to PDE5 activation caused by cGMP-binding to its regulatory GAF domain. Activation is paralleled by phosphorylation whose precise function remains unknown.

Here, we report reconstitution of all features of the NO-induced cGMP response in HEK cells by coexpressing NO-sensitive GC and PDE5. The spike-like cGMP response was blunted when PDE5 phosphorylation was enhanced by additional overexpression of cGMP-dependent protein kinase (PKG). Analysis of PDE5 activation in vitro revealed a discrepancy between the cGMP concentrations required for activation (µM) and reversal of activation (nM) indicating the conversion of a low affinity state to a high affinity state upon binding of cGMP. Phosphorylation even increased the high apparent affinity enabling PDE5 activation to persist at extremely low cGMP concentrations.

Our data suggest that the spike-like shape and the desensitization of the cGMP response are potentially inherent to every GC- and PDE5-expressing cell. Phosphorylation of PDE5 appears to act as memory switch for activation leading to long-term desensitization of the signaling pathway.

*Corresponding author. E-mail: andreas.friebe{at}ruhr-uni-bochum.de






Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Copyright © 2004 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.